sgp130 in Chronic Human Liver Disease
Study of IL-6 Transsignaling in Chronic Human Liver Disease
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1070
- Hopital Erasme - Dpt of Gastroenterology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Alcohol excess intake and suspected liver disease
- Alcohol excess intake and clinical liver cirrhosis
- chronic hepatitis C virus infection and suspected liver disease
- chronic hepatitis C virus infection and clinical liver cirrhosis
Exclusion Criteria:
- other (superimposed) liver disease
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
alcoholic liver disease
alcoholic liver disease patients undergoing a transjugular liver biospy in our institution
|
|
chronic HCV hepatitis
chronic HCV hepatitis patients undergoing a transjugular liver biopsy in our institution
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Arnaud Lemmers, MD, Erasme Hospital, Gastroenterology Dpt
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Chemically-Induced Disorders
- Digestive System Diseases
- Alcohol-Related Disorders
- Substance-Related Disorders
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Flaviviridae Infections
- Hepatitis, Viral, Human
- Hepatitis, Chronic
- Hepatitis
- Alcohol-Induced Disorders
- Liver Diseases
- Hepatitis C
- Hepatitis C, Chronic
- Liver Diseases, Alcoholic
Other Study ID Numbers
Other Study ID Numbers
- AL-gp130
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.